ESWI Airborne's Podcast
In this educational podcast series, our host Clare Taylor talks with the members and partners of ESWI, the European Scientific Working Group on Influenza about their work with acute respiratory viruses such as influenza, sars-CoV-2 and RSV. Clare unearths career choices and paths discovering what brought these distinguished members to become experts in their respective fields. As listeners, we get acquainted with the fascinating world of viruses while she asks thought-provoking questions on issues ranging from how to keep viruses at bay, how vaccines work, why vaccination is important to certain risk groups, how to tackle fake news, and much, much more. This podcast series is adapted to the level of interest of healthcare professionals, patients belonging to risk groups, policy-makers and the public at large. Its purpose is to convey the thoughts and points of view of our guest speakers. Its purpose is not to provide specific medical advice to individuals or substitute consultation with medical practitioners.
ESWI Airborne's Podcast
Intervention Strategies: RSV - the bumpy road towards a vaccine
•
European Scientific Working Group on Influenza (ESWI)
•
Season 5
•
Episode 1
Tremendously exciting times and possibly underestimating the enormity of its impact. These are some of the comments we hear when experts share their insights on the recently available RSV vaccines. We are told about the disastrous first attempts of a vaccine 60 years ago and some of the road bumps leading to today’s success. In this episode, join us as we delve into the history, challenges, and triumphs of RSV vaccine development. Our renowned speakers give detailed accounts of the new RSV vaccines, including target population, critical gaps in vaccination for vulnerable groups, national immunisation programmes and the urgency of expanding access to resource poor settings.
RSV and the bumpy road towards a vaccine is supported by Moderna.
